Document reference

2015/0309(CNS)  
Subjecting the new psychoactive substance 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures  
Basic information  

2015/0309(CNS)

CNS - Consultation procedure
Decision


Subject
4.20.03 Drug addiction, alcoholism, smoking
7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed

 

Key players  
Key events  
18/12/2015
Initial legislative proposal published
21/12/2015
Legislative proposal published
11/04/2016
Committee referral announced in Parliament
28/04/2016
Vote in committee
10/05/2016
Committee report tabled for plenary, 1st reading/single reading
08/06/2016
Results of vote in Parliament
08/06/2016
Decision by Parliament
27/06/2016
Act adopted by Council after consultation of Parliament
27/06/2016
End of procedure in Parliament
02/07/2016
Final act published in Official Journal
Technical information  
Procedure reference
2015/0309(CNS)
Procedure type
CNS - Consultation procedure
Procedure subtype
Legislation
Legislative instrument
Decision
Other legal basis
Rules of Procedure EP 159
Stage reached in procedure
Procedure completed
Committee dossier
LIBE/8/05453
Documentation gateway  
  • European Parliament 
    Committee draft report
       
    16/03/2016
    EP
     
    Committee report tabled for plenary, 1st reading/single reading
       
    10/05/2016
    EP
    Text adopted by Parliament, 1st reading/single reading
       
    08/06/2016
    EP
  • Council of the EU 
    Legislative proposal
     
    21/12/2015
    CSL
  • European Commission 
    Initial legislative proposal
     
    18/12/2015
    EC
  • All 
    Initial legislative proposal
       
    18/12/2015
    EC
    Legislative proposal
       
    21/12/2015
    CSL
    Committee draft report
       
    16/03/2016
    EP
     
    Committee report tabled for plenary, 1st reading/single reading
       
    10/05/2016
    EP
    Text adopted by Parliament, 1st reading/single reading
       
    08/06/2016
    EP
Final act